• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

AAV9的感染性受化学修饰衣壳残基的特定位置和程度影响。

The infectivity of AAV9 is influenced by the specific location and extent of chemically modified capsid residues.

作者信息

Milagros Sergio, de Erenchun Pablo Ramírez-Ruiz, Guembe Maite, Carte Beatriz, Méndez Miriam, Uribarri Ander, Aldabe Rafael

机构信息

DNA and RNA Medicine Division, CIMA Universidad de Navarra, 31008, Pamplona, Spain.

出版信息

J Biol Eng. 2024 May 14;18(1):34. doi: 10.1186/s13036-024-00430-7.

DOI:10.1186/s13036-024-00430-7
PMID:38745236
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11092203/
Abstract

BACKGROUND

Several treatments for genetic diseases utilizing recombinant adeno-associated viruses (AAVs) have recently gained approval. However, the development of a greater number of therapeutic AAVs is constrained by certain limitations. While extensive efforts have concentrated on screening AAV genetic libraries, an alternative strategy involves modifying the AAV capsid by attaching various moieties. The capsid of AAV plays a pivotal role in transducing target cells and evading immune responses, making modifications a key avenue for engineering improved variants.

RESULTS

In our study, we replaced specific AAV9 capsid residues with an unnatural amino acid bearing a bioorthogonal group, identifying four positions with no adverse impact on production. Utilizing click chemistry, we attached varying proportions of Cy5.5 to these positions, allowing us to assess the impact of these modifications on AAV9 infectivity in cultured cells. Our findings reveal that both the position and degree of capsid modification significantly affect AAV transduction. While higher amounts of attached molecules lead to an increased number of AAV genomes within cells, this does not positively impact transgene expression. Conversely, a negative impact on transgene expression is observed when the AAV capsid is highly modified, with the degree of this effect associated with the modified residue.

CONCLUSION

Careful control of both the degree and specific position of capsid modifications is crucial for optimizing transduction efficiency and minimizing undesired effects on transgene expression. These results underscore the importance of precision in AAV capsid modification to achieve optimal transduction efficiency while mitigating potential drawbacks on transgene expression.

摘要

背景

最近,几种利用重组腺相关病毒(AAV)治疗遗传疾病的方法已获得批准。然而,更多治疗性AAV的开发受到某些限制。虽然大量工作集中在筛选AAV基因文库上,但另一种策略是通过连接各种基团来修饰AAV衣壳。AAV的衣壳在转导靶细胞和逃避免疫反应中起关键作用,因此修饰是构建改良变体的关键途径。

结果

在我们的研究中,我们用带有生物正交基团的非天然氨基酸取代了特定的AAV9衣壳残基,确定了四个对生产没有不利影响的位置。利用点击化学,我们将不同比例的Cy5.5连接到这些位置,从而能够评估这些修饰对培养细胞中AAV9感染性的影响。我们的研究结果表明,衣壳修饰的位置和程度都会显著影响AAV的转导。虽然附着分子的量增加会导致细胞内AAV基因组数量增加,但这对转基因表达没有积极影响。相反,当AAV衣壳高度修饰时,会观察到对转基因表达有负面影响,这种影响的程度与修饰的残基有关。

结论

仔细控制衣壳修饰的程度和特定位置对于优化转导效率和最小化对转基因表达的不良影响至关重要。这些结果强调了在AAV衣壳修饰中精确性的重要性,以实现最佳转导效率,同时减轻对转基因表达的潜在不利影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b3a3/11092203/7b243c02be9f/13036_2024_430_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b3a3/11092203/847ca060a6d2/13036_2024_430_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b3a3/11092203/6de855e6dace/13036_2024_430_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b3a3/11092203/4ba6d27254e6/13036_2024_430_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b3a3/11092203/764c755e3ec4/13036_2024_430_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b3a3/11092203/7b243c02be9f/13036_2024_430_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b3a3/11092203/847ca060a6d2/13036_2024_430_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b3a3/11092203/6de855e6dace/13036_2024_430_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b3a3/11092203/4ba6d27254e6/13036_2024_430_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b3a3/11092203/764c755e3ec4/13036_2024_430_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b3a3/11092203/7b243c02be9f/13036_2024_430_Fig5_HTML.jpg

相似文献

1
The infectivity of AAV9 is influenced by the specific location and extent of chemically modified capsid residues.AAV9的感染性受化学修饰衣壳残基的特定位置和程度影响。
J Biol Eng. 2024 May 14;18(1):34. doi: 10.1186/s13036-024-00430-7.
2
Context-Specific Function of the Engineered Peptide Domain of PHP.B.工程化肽结构域 PHP.B 的上下文特定功能
J Virol. 2021 Sep 27;95(20):e0116421. doi: 10.1128/JVI.01164-21. Epub 2021 Aug 4.
3
The AAV9 Variant Capsid AAV-F Mediates Widespread Transgene Expression in Nonhuman Primate Spinal Cord After Intrathecal Administration.鞘内注射 AAV9 变体衣壳 AAV-F 可介导非人类灵长类动物脊髓中的广泛转基因表达。
Hum Gene Ther. 2022 Jan;33(1-2):61-75. doi: 10.1089/hum.2021.069. Epub 2021 Aug 26.
4
Structural and Biophysical Analysis of Adeno-Associated Virus Serotype 2 Capsid Assembly Variants.腺相关病毒血清型 2 衣壳组装变体的结构和生物物理分析。
J Virol. 2023 Jul 27;97(7):e0177222. doi: 10.1128/jvi.01772-22. Epub 2023 Jun 13.
5
Precise Manipulation of the Site and Stoichiometry of Capsid Modification Enables Optimization of Functional Adeno-Associated Virus Conjugates.衣壳修饰位点和化学计量的精确操纵可实现功能性腺相关病毒缀合物的优化。
Bioconjug Chem. 2024 Jan 17;35(1):64-71. doi: 10.1021/acs.bioconjchem.3c00411. Epub 2023 Dec 16.
6
Mapping an Adeno-associated Virus 9-Specific Neutralizing Epitope To Develop Next-Generation Gene Delivery Vectors.绘制腺相关病毒 9 特异性中和表位以开发新一代基因传递载体。
J Virol. 2018 Sep 26;92(20). doi: 10.1128/JVI.01011-18. Print 2018 Oct 15.
7
Tracking Adeno-Associated Virus Capsid Evolution by High-Throughput Sequencing.通过高通量测序追踪腺相关病毒衣壳进化。
Hum Gene Ther. 2020 May;31(9-10):553-564. doi: 10.1089/hum.2019.339. Epub 2020 Mar 5.
8
Site Specific Modification of Adeno-Associated Virus Enables Both Fluorescent Imaging of Viral Particles and Characterization of the Capsid Interactome.腺相关病毒的位点特异性修饰使病毒粒子的荧光成像和衣壳相互作用组的表征成为可能。
Sci Rep. 2017 Nov 7;7(1):14766. doi: 10.1038/s41598-017-15255-2.
9
A Rationally Engineered Capsid Variant of AAV9 for Systemic CNS-Directed and Peripheral Tissue-Detargeted Gene Delivery in Neonates.一种经过合理设计的AAV9衣壳变体,用于新生儿系统性中枢神经系统定向且外周组织脱靶的基因递送。
Mol Ther Methods Clin Dev. 2018 Mar 16;9:234-246. doi: 10.1016/j.omtm.2018.03.004. eCollection 2018 Jun 15.
10
Intravenous administration of the adeno-associated virus-PHP.B capsid fails to upregulate transduction efficiency in the marmoset brain.静脉注射腺相关病毒-PHP.B衣壳未能提高狨猴大脑中的转导效率。
Neurosci Lett. 2018 Feb 5;665:182-188. doi: 10.1016/j.neulet.2017.11.049. Epub 2017 Nov 24.

引用本文的文献

1
Engineering Targeted Gene Delivery Systems for Primary Hereditary Skeletal Myopathies: Current Strategies and Future Perspectives.用于原发性遗传性骨骼肌病的靶向基因递送系统工程:当前策略与未来展望
Biomedicines. 2025 Aug 16;13(8):1994. doi: 10.3390/biomedicines13081994.

本文引用的文献

1
Mannose-coupled AAV2: A second-generation AAV vector for increased retinal gene therapy efficiency.甘露糖偶联的腺相关病毒2型:一种用于提高视网膜基因治疗效率的第二代腺相关病毒载体。
Mol Ther Methods Clin Dev. 2024 Jan 17;32(1):101187. doi: 10.1016/j.omtm.2024.101187. eCollection 2024 Mar 14.
2
Novel chemical tyrosine functionalization of adeno-associated virus improves gene transfer efficiency in liver and retina.新型腺相关病毒酪氨酸化学功能化提高肝脏和视网膜中的基因转导效率。
Biomed Pharmacother. 2024 Feb;171:116148. doi: 10.1016/j.biopha.2024.116148. Epub 2024 Jan 16.
3
Rationale and strategies for the development of safe and effective optimized AAV vectors for human gene therapy.
用于人类基因治疗的安全有效优化腺相关病毒载体开发的原理与策略
Mol Ther Nucleic Acids. 2023 May 17;32:949-959. doi: 10.1016/j.omtn.2023.05.014. eCollection 2023 Jun 13.
4
Chemical modification of AAV9 capsid with N-ethyl maleimide alters vector tissue tropism.用 N-乙基马来酰亚胺对 AAV9 衣壳进行化学修饰改变了载体的组织嗜性。
Sci Rep. 2023 May 25;13(1):8436. doi: 10.1038/s41598-023-35547-0.
5
The Expanded Central Dogma: Genome Resynthesis, Orthogonal Biosystems, Synthetic Genetics.扩展中心法则:基因组重合成、正交生物系统、合成遗传学。
Annu Rev Biophys. 2023 May 9;52:413-432. doi: 10.1146/annurev-biophys-111622-091203.
6
Aptamer-programmable adeno-associated viral vectors as a novel platform for cell-specific gene transfer.适配体可编程腺相关病毒载体作为细胞特异性基因转移的新型平台。
Mol Ther Nucleic Acids. 2023 Jan 21;31:383-397. doi: 10.1016/j.omtn.2023.01.007. eCollection 2023 Mar 14.
7
Gene Therapy with Etranacogene Dezaparvovec for Hemophilia B.用依特那考基因德扎帕罗韦克治疗B型血友病的基因疗法。
N Engl J Med. 2023 Feb 23;388(8):706-718. doi: 10.1056/NEJMoa2211644.
8
AAV vectors: The Rubik's cube of human gene therapy.AAV 载体:人类基因治疗的魔方。
Mol Ther. 2022 Dec 7;30(12):3515-3541. doi: 10.1016/j.ymthe.2022.09.015. Epub 2022 Oct 5.
9
Valoctocogene Roxaparvovec Gene Therapy for Hemophilia A.静脉注射用罗沙帕洛维治疗 A 型血友病的基因疗法。
N Engl J Med. 2022 Mar 17;386(11):1013-1025. doi: 10.1056/NEJMoa2113708.
10
Long-term efficacy and safety of eladocagene exuparvovec in patients with AADC deficiency.AADC 缺乏症患者接受 eladocagene exuparvovec 治疗的长期疗效和安全性。
Mol Ther. 2022 Feb 2;30(2):509-518. doi: 10.1016/j.ymthe.2021.11.005. Epub 2021 Nov 8.